β1 Integrin was found to be inhibited in CSNK2β knockdown cells, which is a majorly expressed integrin and has been reported to actively be involved in metastasis and has attracted considerable attention as a target for immunotherapy in breast cancer (Park et al., 2008[40]). This evidence concerns the gene CSNK2B and breast carcinoma.